Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Resting-state EEG, impulsiveness, and personality in daily and nondaily smokers.

Rass O, Ahn WY, O'Donnell BF.

Clin Neurophysiol. 2016 Jan;127(1):409-18. doi: 10.1016/j.clinph.2015.05.007. Epub 2015 May 14.

PMID:
26051750
2.

Tobacco use in bipolar disorder.

Thomson D, Berk M, Dodd S, Rapado-Castro M, Quirk SE, Ellegaard PK, Berk L, Dean OM.

Clin Psychopharmacol Neurosci. 2015 Apr 30;13(1):1-11. doi: 10.9758/cpn.2015.13.1.1.

3.

Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward.

Freeman TP, Das RK, Kamboj SK, Curran HV.

Soc Cogn Affect Neurosci. 2015 Jan;10(1):85-92. doi: 10.1093/scan/nsu026. Epub 2014 Feb 12.

4.

Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans.

Lofwall MR, Nuzzo PA, Campbell C, Walsh SL.

Exp Clin Psychopharmacol. 2014 Jun;22(3):238-47. doi: 10.1037/a0035165. Epub 2014 Jan 27.

5.

Acute phenylalanine/tyrosine depletion reduces motivation to smoke cigarettes across stages of addiction.

Venugopalan VV, Casey KF, O'Hara C, O'Loughlin J, Benkelfat C, Fellows LK, Leyton M.

Neuropsychopharmacology. 2011 Nov;36(12):2469-76. doi: 10.1038/npp.2011.135. Epub 2011 Jul 20.

6.

Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.

Dutra SJ, Stoeckel LE, Carlini SV, Pizzagalli DA, Evins AE.

Psychopharmacology (Berl). 2012 Jan;219(1):25-34. doi: 10.1007/s00213-011-2373-6. Epub 2011 Jun 22.

7.

Secondhand smoke exposure and mental health among children and adolescents.

Bandiera FC, Richardson AK, Lee DJ, He JP, Merikangas KR.

Arch Pediatr Adolesc Med. 2011 Apr;165(4):332-8. doi: 10.1001/archpediatrics.2011.30.

8.

Secondhand smoke exposure and depressive symptoms.

Bandiera FC, Arheart KL, Caban-Martinez AJ, Fleming LE, McCollister K, Dietz NA, Leblanc WG, Davila EP, Lewis JE, Serdar B, Lee DJ.

Psychosom Med. 2010 Jan;72(1):68-72. doi: 10.1097/PSY.0b013e3181c6c8b5. Epub 2009 Nov 30. Erratum in: Psychosom Med. 2010 Apr;72(3):331.

9.
10.

The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Pak AC, Ashby CR Jr, Heidbreder CA, Pilla M, Gilbert J, Xi ZX, Gardner EL.

Int J Neuropsychopharmacol. 2006 Oct;9(5):585-602. Epub 2006 Aug 31.

11.

Aripiprazole therapy for nicotine dependence.

Ramaswamy S, Bhatia SC.

Prim Care Companion J Clin Psychiatry. 2006;8(1):47-9. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk